XML 29 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 15,182 $ 369 $ 146,556,418 $ (136,281,630) $ 10,290,339
Balance, shares at Dec. 31, 2022 1,518,158 3,677,775      
Stock-based compensation:          
Restricted share units $ 9 4,633,655 4,633,664
Restricted share units, shares   89,840      
Options 3,141,803 3,141,803
Common stock 7,500 7,500
Common stock, shares   1,442      
Conversion of Series B Convertible Preferred Stock into common stock $ (1,200) $ 12 1,188
Conversion of Series B Convertible Preferred Stock into common stock, shares (120,000) 120,000      
Issuance and sale of common stock, net of issuance costs $ 81 2,348,692 2,348,773
Issuance and sale of common stock, net of issuance costs, shares   817,860      
Net loss (10,417,704) (10,417,704)
Balance at Dec. 31, 2023 $ 13,982 $ 471 156,689,256 (146,699,334) 10,004,375
Balance, shares at Dec. 31, 2023 1,398,158 4,706,917      
Stock-based compensation:          
Restricted share units $ 10 985,028 985,038
Restricted share units, shares   97,827      
Options 1,827,528 1,827,528
Net loss (8,979,381) (8,979,381)
Common stock issued in connection with warrant exchange [1] $ 200 4,742,043 4,742,243
Common stock issued in connection with warrant exchange, shares [1]   2,000,000      
Return and cancellation of shares in lieu of payroll tax withholding $ (4) (48,406) (48,410)
Return and cancellation of shares in lieu of payroll tax withholding, shares   (34,825)      
Common stock issued in connection with abeyance shares $ 15 (15)
Common stock issued in connection with abeyance shares, shares   150,000      
Balance at Dec. 31, 2024 $ 13,982 $ 692 $ 164,195,434 $ (155,678,715) $ 8,531,393
Balance, shares at Dec. 31, 2024 1,398,158 6,919,919      
[1] Represents the aggregate fair value of 3,351,580 shares of common stock, which includes 2,150,000 shares that have been issued and 1,201,580 shares held in abeyance. See Note 6 - Stockholders’ Equity - Warrant Exercise and Issuance and Note 9 - Fair Value Measurement for additional details.